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Abstract
Background: Current insights into the effects of iron deficiency in tumour cells are not commensurate with the
importance of iron in cell metabolism. Studies have predominantly focused on the effects of oxygen or glucose
scarcity in tumour cells, while attributing insufficient emphasis to the inadequate supply of iron in hypoxic regions.
Cellular responses to iron deficiency and hypoxia are interlinked and may strongly affect tumour metabolism.
Methods: We examined the morphological, proteomic, and metabolic effects induced by two iron
chelators—deferoxamine (DFO) and di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)—on
MDA-MB-231 and MDA-MB-157 breast cancer cells.
Results: These chelators induced a cytoplasmic massive vacuolation and accumulation of lipid droplets (LDs),
eventually followed by implosive, non-autophagic, and non-apoptotic death similar to methuosis. Vacuoles and LDs
are generated by expansion of the endoplasmic reticulum (ER) based on extracellular fluid import, which includes
unsaturated fatty acids that accumulate in LDs. Typical physiological phenomena associated with hypoxia are
observed, such as inhibition of translation, mitochondrial dysfunction, and metabolic remodelling. These
survival-oriented changes are associated with a greater expression of epithelial/mesenchymal transcription markers.
Conclusions: Iron starvation induces a hypoxia-like program able to scavenge nutrients from the extracellular
environment, and cells assume a hypertrophic phenotype. Such survival strategy is accompanied by the ER-
dependent massive cytoplasmic vacuolization, mitochondrial dysfunctions, and LD accumulation and then evolves
into cell death. LDs containing a greater proportion of unsaturated lipids are released as a consequence of cell
death. The consequence of the disruption of iron metabolism in tumour tissue and the effects of LDs on
intercellular communication, cancer–inflammation axis, and immunity remain to be explored. Considering the
potential benefits, these are crucial subjects for future mechanistic and clinical studies.
Keywords: Breast cancer, cytoplasm vacuolation, endoplasmic reticulum stress, iron chelation, lipid droplets,
macropinocytosis, mitochondria dysfunctions, methuotic cell death, hypoxia, Raman spectroscopy
Background
Iron is an essential component of several cellular enzymes,
such as catalases, peroxidases, cytochromes, ribonucleotide
reductase, desaturases, and aconitase, which are crucial for
physiological functions and have been implicated in several
diseases, including cancer, because of alterations in iron
metabolism [1]. Adequate iron supply is critical for various
cellular processes, including DNA synthesis and cell cycle
progression. Many in vitro and in vivo studies have demon-
strated that compared with normal cells, cancer cells are
more sensitive to iron deprivation because of their marked
Fe requirements [2]. Furthermore, their strong dependency
on iron is evidenced by their increased expression of trans-
ferrin receptors compared with that of normal cells. In vitro
and animal studies have also indicated the antitumour
activity of several iron chelators [3–5].
Clinical data support the concept that iron deficiency in-
creases angiogenesis and causes breast cancer recurrence
[6]. Specifically, iron deficiency can contribute to the high
recurrence of breast cancer in premenopausal women,
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whereas iron load might play a role in the metastasization
of breast cancer in postmenopausal women.
Iron chelators are known to induce apoptosis in several
types of proliferating cells [7] and are therefore considered
promising anti-proliferative agents in the treatment of hu-
man cancers. Iron chelators, such as deferoxamine (DFO),
deferiprone, and deferasirox, have several advantages: they
have been clinically approved for iron overload disorders
[8], they have a well-studied, long-term use toxicity profile,
and experimental results could be readily translated into
clinical trials for cancer. Nevertheless, it is crucial to con-
sider several side effects related to their use, including
myelosuppression, hypoxia, and methemoglobinaemia, as
observed from clinical trials [9].
DFO is a clinically approved non-toxic iron chelator
that has been effectively used for long-term iron chela-
tion therapy in beta-thalassemia and other iron overload
disorders. DFO has also been reported to have some
antitumour activity [10–13]. Novel chelators based on
the di-2-pyridylketone thiosemicarbazone (DpT) scaf-
fold, such as di-2-pyridylketone 4,4-dimethyl-3-thiosemi-
carbazone (Dp44mT), induce iron sequestration and also
form redox-active metal complexes that demonstrate po-
tent and selective antitumour activity [14]. Notably,
Dp44mT and its analogues possess broad anti-cancer
and anti-metastatic activity, in vitro and in vivo, against
several aggressive solid tumours [15–20].
Relevant studies have focused on the causality between
iron chelation and cancer cell death, without considering
that substantial regions of cancers often grow in hypoxic
conditions owing to the lack of a functional vasculature.
The amount of bio-available iron is often limited in poorly
vascularised areas, and the iron uptake in cancer cells is in-
adequate to fulfil their need. Moreover, the lack of cellular
iron content has an essential role in positively regulating
hypoxia-inducible factor (HIF) protein stability and there-
fore hypoxia mechanisms, even under non-hypoxic condi-
tions [21]. Thus, cancer cells are more susceptible to iron
depletion than non-cancer cells, a phenomenon we have
termed iron addiction; however, it is important to note that
cancer cells adapt in response to low iron levels, directly
affecting cancer cell metabolism [22]. Recent findings on
medulloblastoma cell lines indicate that modulation of
iron-related proteins during hypoxia may increase cell pro-
liferation as well as tumour aggression and stemness [23].
Oxygen and iron are intimately linked in producing signals
through the hypoxia response pathway, and they exert con-
siderable influence on cancer cell metabolism [24].
Based on these observations, we aimed to understand
the morphological, proteomic, and metabolic effects of
iron depletion in breast cancer cells with a deeper insight
into the cellular effects and drawbacks of iron starvation.
We combined biochemistry, microscopy, flow cytometry,
and mass spectrometry-based methods to investigate the
cellular and molecular events induced by DFO or
Dp44mT in two human breast cancer cell lines, MDA-
MB-231 and MDA-MB-157.
Cellular stress and organelle dysfunctions due to the dis-
ruption of cellular homeostasis were observed, and these
events led to cell death. A dramatic increase in endoplasmic
reticulum (ER) complexity, with the appearance of large vac-
uoles and the accumulation of lipid droplets (LDs), accom-
panied mitochondrial dysfunction and bioenergetics collapse
and was followed by cell death and LD leakage. The results
of this study are expected to provide important insights into
the fundamental molecular mechanisms of the adaptation of
breast cancer cells to iron limitation.
Methods
Cell lines and culture
MDA-MB-231 and MDA-MB-157 breast cancer cell
lines were obtained from the American Type Culture
Collection (ATCC, Manassas, VA, USA). They are char-
acterised as triple-negative/basal B mammary carcinoma
and considered models of triple-negative breast cancer
growth and progression. Cell lines were maintained in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco)
containing 10% heat-inactivated foetal bovine serum
(FBS; HyClone), DMEM w/ 4.5 g/L glucose w/o L-
glutamine at 37 °C and 5% CO2 in air.
Reagents
Dp44mT and DFO were purchased from Sigma-Aldrich.
Dp44mT was dissolved in dimethyl sulfoxide (DMSO)
and further diluted to a final concentration of 5 μM in the
culture medium, whereas DFO was diluted to a final con-
centration of 250 μM in the culture medium and used at a
final concentration of 100 μM. Cells were incubated with
either control media containing or not containing DMSO
at 0.05% (v/v) to match the concentration of the dissolved
Dp44mT or DFO.
Assessment of antiproliferative activity
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium brom-
ide thiazolyl blue (MTT) assay was performed in 48-
multiwell plates containing MDA-MB-231 cells, seeded at a
concentration of 1.8 × 104 cells per well. After 24 h, MDA-
MB-231 cells were treated with 5 μM Dp44mT or with
100 μM DFO for 120 h. Cell proliferation was assessed by
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide; thiazolyl blue) assay according to the manufac-
turer’s recommendations (Sigma). Absorbance intensity
was quantified at 492 nm using a microplate reader (Infinite
200, Tecan). Data are shown as mean ± standard error of
the mean (SEM) of quadruplicated wells and are represen-
tative of three independent experiments. Statistical tests
were performed using GraphPad Prism version 5.0 (Graph-
Pad Software Inc.).
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Sample preparation, SDS-PAGE, and immunoblotting
MDA-MB-231 and MDA-MB-157 cell lines were treated
with the iron chelators for the times indicated earlier. Cell
pellets were solubilised as previously described [25]. Protein
concentrations were detected using a bicinchoninic acid
(BCA) kit (Pierce) according to the manufacturer’s instruc-
tions, and SDS-PAGE and electroblotting were performed,
as previously described [26]. The antibodies used for west-
ern blotting analyses are listed in Additional file 1.
Mitochondrial membrane potential analysis
After treating cells with the iron chelators for the times in-
dicated earlier, the mitochondrial membrane potential of
the cells was detected using a MitoProbe™ JC-1 assay kit for
flow cytometry (Thermo Fisher Scientific). Flow cytometry
analyses were performed as previously described [27].
Fluorescence microscopy
The subcellular location of various proteins was visua-
lised by fluorescence microscopy (Eclipse E1000, Nikon
Instruments, Inc.). To visualise different subcellular
compartments, we used antibodies for RAB5, RAB7,
LAMP1, NDRG1, and RTN4 as markers for the ER and
LysoTracker red (50 nM; Life Technologies) as a marker
for lysosomes. To visualise mitochondria in live cells, we
stained the cells with the vital dye Rhodamine 123
(500 ng/mL; Sigma-Aldrich) for 15 min at 37 °C. To
visualise nuclei in live cells, we stained the cells with the
cell-permeable DNA dye 4′,6-diamidino-2-phenylindole
(DAPI) (10 μM; Molecular Probes) for 15 min at 37 °C.
Confocal microscopy
Confocal laser scanning microscopy was performed using
the Leica TCS SP8 X microscope (Leica Microsystems
GmbH).
Nano-scale LC-MS/MS analysis
Cells were lysed in 50 μL of 0.1% RapidGest SF Surfactant
(Waters) and diluted in 50 mM ammonium bicarbonate
(pH 8.0). After reduction and alkylation, the proteins were
digested with trypsin sequence grade (Roche) for 16 h at 37 °
C using a protein:trypsin ratio of 20:1 [28]. LC-ESI-MS/MS
analysis was performed on a Dionex UltiMate 3000 HPLC
System with a PicoFrit ProteoPrep C18 column (200 mm in
length and with an internal diameter of 75 μm) (New Ob-
jective). The eluate was electrosprayed into an LTQ Orbitrap
Velos (Thermo Fisher Scientific) through a Proxeon nanoe-
lectrospray ion source (Thermo Fisher Scientific) [29]. Four
technical replicate analyses of each sample were performed.
Data acquisition was controlled by Xcalibur 2.0 and Tune 2.
4 software (Thermo Fisher Scientific).
Mass spectra were analysed using the MaxQuant soft-
ware (version 1.3.0.5). Enzyme specificity was set to trypsin.
Carbamidomethylcysteine was set as a fixed modification,
and N-terminal acetylation, methionine oxidation, and as-
paragine/glutamine deamidation were set as variable modi-
fications. The spectra were searched by the Andromeda
search engine against the human Uniprot sequence data-
base (release 29.06.2015). Protein identification required at
least one unique or razor peptide per protein group. Quan-
tification in MaxQuant was performed using the built-in
XIC-based label-free quantification (LFQ) algorithm [30]
using fast LFQ. The required false positive rate was set to
1% at the peptide level and 1% at the protein level. Statis-
tical analyses [31] were performed using the Perseus soft-
ware (version 1.4.0.6, www.biochem.mpg.de/mann/tools/).
Only proteins present and quantified in at least 3 out of 4
technical repeats were considered positively identified;
2478, 2488, and 2496 proteins were identified in untreated,
DFO-, and Dp44mT-treated cells, respectively; 108 proteins
were exclusively expressed in untreated/control cells, 54
proteins in DFO/cells, and 137 proteins in Dp44mT/cells.
An ANOVA test (false discovery rate 0.05) was carried out
to identify proteins differentially expressed among the three
conditions: 1682 out of 2149 common proteins differed
with statistical significance and were selected for further
analyses. In particular, we focused on the differential prote-
omics between proteins expressed in untreated cells and
proteins expressed in DFO- or Dp44mT-treated cells.
Differential expression was considered significant if (1) a
protein was present only in untreated or treated cells or (2)
its normalised (according to the LFQ algorithm) intensity
resulted in a statistical difference, as calculated by the
Welch’s t-test (t-test cut-off at p value = 0.0167). The MS
proteomics data have been deposited in the ProteomeX-
change Consortium via the PRIDE partner repository [32]
with the dataset identifier PXD007595.
Gene ontology (GO)
The Search Tool for the Retrieval of INteracting Genes/
proteins (STRING) database (version 10.5, Database
issue: D412–416) [33] was used for prediction of Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways
[34–36]. A GO scatterplot was constructed in Excel.
Oil red O staining
To determine the presence of LD accumulation within
MDA-MB-231 and MDA-MB-157 cells, Oil Red O (Sigma-
Aldrich) staining was performed. To visualise cell nuclei,
samples were stained with haematoxylin (Sigma-Aldrich).
Cells were imaged on a Leica DM IRB microscope (Leica
Microsystems).
Fatty acid (FA) quantification in lipid droplets
Cells were cultured in 10-cm dishes for 96 h in the pres-
ence of 100 μM DFO or Dp44mT. The presence of LDs
was evaluated with Oil Red O staining. Cell debris was
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recovered from the plates and LDs purified by density
sucrose gradient [37].
Lipids were prepared by homogenizing the samples in
ethanol containing (50 ppm) butylated hydroxy toluene
(BHT) to avoid oxidation [38]. A lipid chromatogram was
obtained by gas chromatography–mass spectrometry
(GC-MS) analysis using a Shimadzu gas chromatograph
equipped with a quadrupole mass spectrometer for elec-
tron impact ionisation (GC-MS-QP2010). An SH Stabi-
lwax DA column (30m in length, 0.25mm in diameter,
and with a film thickness 0.25 μm) was used to separate
the FA methyl ester at a flow rate of 1.0 mL/min. The in-
jector temperature was set to 200 °C and the transfer line
temperature to 280 °C. The GC oven was programmed as
follows: after 2min at 50 °C, the temperature was in-
creased at 30 °C/min to 150 °C, then at 15 °C/min to 230 °
C. The total run duration was 25min. GC-MS analysis
was conducted in the full scan mode (m/z 35–600). Quali-
tative analysis was based on the characteristic ions of the
FA methyl esters and their relative retention times. Quan-
titative analysis was based on the ratio between the peak
area of each FA and the corresponding internal standard
peak area, using the respective standard curves.
Raman spectroscopy
To perform coherent anti-Stokes Raman scattering (CARS)
imaging, a home-built laser scanning multi-modal micro-
scope, described previously [39], was utilised. To acquire
CARS images, the treated cells were placed under the laser
focus of the microscope, and the laser spot was galvo-
scanned over the 50 × 50 μm2 sample area at two fixed
pump-Stokes frequency detuning: 2850 cm− 1 (for lipid
molecules) and 3050 cm− 1 (for medium and vacuoles).
Spectral profiles and spatially resolved chemical maps of
the pure chemical components were generated using the
MATLAB tool box MCR-ALS (Multivariate Curve Reso-
lution Alternating Least Squares) algorithm [40, 41]. We
collected two images: one at 2850 cm− 1, indicating the
symmetric vibration of CH2 chains in lipids, and the other
at 3050 cm− 1, indicating the stretching vibration of
hydrogen-bonded water of saline environments. The output
of the software was two matrices (representing the concen-
tration at 2850 cm− 1 and 3050 cm− 1) and two spectra
(representing the two identified species). For the set-up of
the figure, we have plotted these two matrices from gray-
scale to a single-color scale (green for lipids, blue for
medium) and created a composite image thereof with the
FIJI image processing package.
Results
Targeting iron homeostasis induces cell death by
formation of vacuoles
We observed that the treatment of MDA-MB-231 cells
with 100 μM DFO or 5 μM Dp44mT induced extensive
cytoplasmic modifications at different time points (24 h,
48 h, and 72 h). At 48–72 h after treatment with
100 μM DFO, the cells became flattened and showed ex-
tensive vacuolation (Fig. 1a). Cytoplasmic vacuolation
began to be evident at 24 h after Dp44mT treatment; it
was more pronounced after 48 h and involved extensive
regions of the cytoplasm at 72 h. The MTT assay indi-
cated that at 120 h after treatment with 100μM DFO,
MDA-MB-231 cell proliferation was completely blocked
(Fig. 1b). Treatment with 5 μM Dp44mT drastically re-
duced cell proliferation after 48 h and killed all the cells
within 120 h. Evaluation of the cell cycle distribution of
MDA-MB-231 cells after treatment with DFO or
Dp44mT showed that there was a slight increase in the
G2 population (Additional file 2). For both treatments,
the morphology of the cells during death could neither
be classified as apoptotic nor as necrotic.
Western blot analyses revealed that DFO and Dp44mT
induced a very low poly (ADP-ribose) polymerase-1 (PARP)
cleavage and high mobility group box 1 (HMGB1) expres-
sion in cells after 72 h (Fig. 1c). B-cell lymphoma 2 (BCL-2)
expression did not change significantly in response to either
DFO or Dp44mT treatments. The results using biomarkers
of apoptosis and necrosis indicated the irrelevant contribu-
tion of both apoptotic and necrotic cell death pathways.
The levels of p-JNK and p-p38 drastically decreased after
72 h in untreated cells but persisted at high levels in treated
cells; a slight increase in p-AMPK and p-mTOR levels was
observed at 72 h in both untreated and treated cells. JNK
and p38 signalling may be triggered by the redox state-
related perturbations and may regulate expression of apop-
totic downstream genes, preventing apoptosis and promot-
ing cell survival. These results suggest the development of
stress-related compensatory mechanisms to overcome cell
death and permit short-term cell survival.
Proteome analyses
We performed a proteomics analysis to investigate the ef-
fects of DFO and Dp44mT in MDA-MB-231 cells after
treatment for 72 h, when a significant change in phenotype
and morphology was observed. DMSO-treated cells were
used as control. Shotgun label-free quantitative analysis was
performed to examine the differences in global protein ex-
pression. After data filtering, the analysis resulted in the
identification of 2478 (DMSO), 2488 (DFO), and 2496
(Dp44mT) proteins. One hundred eight proteins were ex-
clusively expressed in untreated/control cells, 54 proteins in
DFO/cells, and 137 proteins in Dp44mT/cells (Additional
files 3, 4, 5, 6). An ANOVA test (false discovery rate 0.05)
was carried out to identify proteins differentially expressed
among the three conditions: 1682 out of 2149 common
proteins differed with statistical significance and were se-
lected for further analyses. Figure 2a shows the volcano
plots summarizing the analysis of differentially expressed
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proteins in untreated cells in comparison with proteins
expressed in DFO- or Dp44mT-treated cells.
The differentially expressed proteins for both treatments,
identified in the label-free MS data, were unified and sub-
jected to the analysis of the most significant KEGG path-
ways [35] using STRING software version 10 [33]. The
most statistically significant decreased pathway identified
by KEGG enrichment was Ribosome (#03010; p-value = 3.
57 × 10− 25) with 38 proteins (Fig. 2b). However, to reflect a
multi-functional stress response, several statistically signifi-
cant changes in key processes and pathways were observed,
referable to enhanced glycolysis, reduced translation,
Fig. 1 DFO/Dp44mT-induced vacuolation leads to non-apoptotic/necrotic cell death in MDA-MB-231 breast cancer cells. a Representative images of
MDA-MB-231 cells treated with 100 μM DFO or with 5 μM Dp44mT. The cells were treated with the iron chelators for 48 h and photographed under
an optical microscope. Scale bars: 100 μm. b MDA-MB-231 cells treated with 100 μM DFO or with 5 μM Dp44mT to determine the effects of the two
iron chelators on cell proliferation. An MTT assay analysis indicated that after 24 h, cells treated with DFO or Dp44mT showed a slight decrease in cell
proliferation. After Dp44mT treatment for 48 h, cell proliferation was reduced by 69%, whereas DFO treatment elicited a decrease in cell proliferation
by 45%. After 72 h, Dp44mT treatment resulted in a considerable decrease in cell proliferation (75%), whereas DFO treatment reduced cell proliferation
by 56%. Finally, after 120 h, proliferation was effectively blocked in MDA-MB-231 cells treated with both chelators. c Determination of the expressions
of PARP, HMGB1, BCL-2, phosphorylated p38, JNK, AMPK, and mTOR, following treatment of MDA-MB-231 cells with DFO or Dp44mT. Cells were
treated with 100 μM DFO or 5 μM Dp44mT and the protein levels were examined over a period of 24–72 h. In control samples, no PARP-1 expression
was observed at 72 h. At 116 kDa corresponding to full-length PARP-1, immunoreactivity was detectable in the 24, 48, and 72 h-treated samples. No
cleavage products of PARP-1 were seen at 48 h and 72 h. Weak increase in HMGB1 expression was noted in treated cells after 72 h. No change in the
protein levels of BCL-2 was observed. The increased levels of phosphorylated p38, JNK, AMPK, and mTOR suggest that DFO and Dp44mT induce cell
death by maintaining multiple activated pathways. Tubulin was used as a loading control. d Schematic representation of the effects observed with
DFO or Dp44mT treatments
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Fig. 2 Proteomics analysis of DFO- or Dp44mT-treated cells vs untreated cells. a Volcano plot showing the results of differentially expressed proteins
based on fold change versus t-test probability (Welch difference). Each protein is represented as a dot and is mapped according to its fold change on
the ordinate axis (y), with t-test p-value on the abscissa axis (x). The blue and orange dots indicate up-regulated and down-regulated proteins,
respectively. Grey dots have identification which did not meet the fold and p-value criteria. Some key molecules that changed significantly as a result of
the treatments are indicated. Bubble graphs showing the top 12 down-regulated (panel b) and the top 12 up-regulated (panel c) KEGG pathway terms
plotted against the -log10 (p-value) for proteins obtained from whole-cell lysate from untreated MDA-MB-231 cells compared with those from DFO- or
Dp44mT-treated cells. The size of bubbles represents the number of proteins enriched for each KEGG pathway term. All pathways had a false discovery
rate (FDR) < 0.001
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reduced glucose entry into the tricarboxylic acid (TCA)
cycle, up-regulated glutathione metabolism and glutamino-
lysis, and changes in mRNA, amide, and lipid metabolism.
Significant increases of the amino acid metabolism also
took place as well as reduction–oxidation (redox) homeo-
stasis and NAD metabolism. Taken together, these changes
indicated a metabolic adaptation similar to that sustaining
cancer cell survival during hypoxia [42].
Interrogation of the Ingenuity Pathway Analysis software
highlighted that the canonical and toxicity pathways were
altered by DFO or Dp44mT (Additional file 7). The analysis
of pathways, conducted by combining all the up- and
down-regulated proteins, indicated that EIF2 signalling,
eIF4-p70S6K signalling, mTOR signalling, oxidative stress,
glycolysis, gluconeogenesis, and protein degradation medi-
ated by ubiquitination were the most common and import-
ant pathways affected by DFO and Dp44mT. Tox list
analysis indicated that renal necrosis/cell death pathway,
mitochondrial dysfunction, HIF signalling, oxidative stress,
protein degradation mediated by ubiquitination, and fatty
acid (FA) metabolism were the most affected pathways.
The observed changes can be largely explained by the
induction of severe defects in the Fe–S cluster biogen-
esis/repair, which can profoundly decrease the activities
of respiratory complexes, ribosome biogenesis, and the
TCA cycle, affecting energy production and increasing
oxidative stress. The defects in the Fe–S cluster biogen-
esis might also affect cytosolic aconitase activity and
therefore citrate metabolism, which can disrupt the bal-
ance between glycolysis, FA biosynthesis, and purine ca-
tabolism pathways. An increase in glutamic-oxaloacetic
transaminase (GOT) 1 activity was observed, indicating
a possible increase in glutamine (Gln) metabolism with
an apparently high uptake of Gln through up-regulation
of sodium-dependent neutral amino acid transporter
type 2 (SLC1A5). Along with the metabolic modifica-
tions in the treated cells, we also regarded the reduction
of FA synthase (FASN) as possibly indicative of the re-
duction of lipid synthesis; the up-regulation of perilipin
(PLIN) 2 and PLIN3 was predictive of LD accumulation
[43] and the variation in desaturase levels (decreases in
FA desaturase (FADS) 2 [44] and increases in D4-
dihydroceramide (DhCer) desaturase (DEGS) 1 [45]).
The KEGG list of up-regulated pathways included the
amino sugar and nucleotide sugar metabolic pathways (Fig.
2b and c). The hexosamine biosynthetic pathway (HBP) is
frequently up-regulated in cancer cells with a mesenchymal
phenotype [46]. It is required to sustain sufficient growth fac-
tor signalling and Gln uptake to support cell growth and sur-
vival. Glucose and Gln are both essential for the first
committed step and rate-limiting step of the HBP: the con-
version of fructose-6-phosphate (Fru-6P) to glucosamine-6-
phosphate is required for the glycosylation of the proteins
controlling the O-GlcNAcylation of nuclear and cytoplasmic
proteins. Hypoxic cancer cells have been shown to contain
elevated levels of the HBP genes, including Gln–fructose-6-
phosphate transaminase 1 (GFPT1) (which was overex-
pressed in our study) and GFPT2, and overall O-
GlcNAcylation [47]. Taken together, these data support a
model in which by inducing a hypoxia-like metabolic repro-
gramming, iron chelation could solicit an HBP-based sur-
vival program that can help establish a short-term survival
strategy in MDA-MB-231 cells to avoid apoptosis.
Blocking of autophagy
In principle, iron depletion can induce the activation of
pathways linked to the activation of autophagy. The vacu-
oles formed in response to iron depletion in this study were
similar to the lysosomal structures reported in several au-
tophagic circumstances [48–52]. Thus, we investigated the
possibility that the vacuoles observed in our study were also
associated with autophagy. Microtubule-associated protein
light chain 3 (LC3) and other members of its family are
retained inside autophagosomes. Thus, LC3 is commonly
used as a marker for identifying autophagosomes [53–56].
Positivity for LC3 punctae increased with both DFO and
Dp44mT treatments; however, LC3 was also present in un-
treated cells (Fig. 3a, b). These data were further confirmed
by western blotting analysis, with only a slight increase in
LC3-II lipidated isoforms in treated cells (Fig. 3c).
We investigated lysosomal conditions in MDA-MB-231
cells treated with DFO or Dp44mT using lysosomotropic
metachromatic fluorochrome (LysoTracker) that emits a
red fluorescence at high concentrations within intact lyso-
somes [57]. Quantitative data from flow cytometry indi-
cated that fluorescence increased after DFO and Dp44mT
treatments (Fig. 3d). The cells exposed to Dp44mT accu-
mulated LysoTracker in the cytoplasm, indicating a certain
amount of lysosomal membrane permeabilisation. Control
cells and DFO-treated cells displayed a discrete punctate
fluorescent staining pattern in perinuclear regions with no
fluorescence in the cytoplasm, whereas Dp44mT-treated
cells displayed vacuole staining and some membrane leak-
age, as indicated by the diffusion of fluorescence into the
cytoplasm. However, the LysoTracker staining merged with
LC3 staining only partially.
Lucifer Yellow (LY) is a marker of fluid-phase pinocytosis
that accumulates in secondary lysosomes and cellular
membranes are impermeable to LY [58]. We loaded MDA-
MB-231 cells treated for 48 h with DFO or Dp44mT with
LY in the final 16 h (Fig. 3e). Control cells and DFO-treated
cells had clear punctuate labelling, possibly corresponding
to the lysosomal vesicles; however, the large vacuoles did
not fluoresce or fluoresced scarcely. Dp44mT-treated cells
also had scarce LY-positive punctate vesicles, but often, the
fluorescence was more diffuse throughout the cell body, in-
dicating leakage of LY from the secondary lysosome into
the cytosol.
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Fig. 3 Vacuoles remain distinct from autophagosomes. a Immunofluorescence localisation of LC3 in vacuolated MDA-MB-231 cells. Cells were treated with
DFO or Dp44mT for 48 h, immunostained with anti-LC3 (red) and with anti-tubulin (green) antibodies, and then analysed by confocal microscopy. Blue,
DAPI. The cell population shifts in size and granularity and becomes heterogeneous after DFO or Dp44mT treatments. This is an excerpt of the results
obtained from several (at least three) experiments. There was little overlap between the phase-lucent vacuoles and compartments labelled with markers
for lysosomes (LysoTracker) or autophagosomes (LC3II), suggesting a defect at the late endosome-lysosome boundary. b Western blotting analysis of LC3-I
and LC3-II expression in treated cells for 48 h and the relative Ponceau-stained filter used as a loading control. c Lysotracker staining analysis by flow
cytometry analysis. Results are expressed as mean of the far red (APC-A) fluorescence intensity or forward-scatter (FSC-A) factors (x-axis) and of the
side-scatter (SSC-A) factor (y-axis), i.e. granularity and size, respectively, of untreated and DFO- or Dp44mT-treated MDA-MB-231 cells for 48 h, showing the
increased SSC-A in DFO-treated cells. DMSO-treated cells have lower signal intensity. d Confocal microscopy analysis of induced vacuoles sequestering
lucifer yellow (LY). Differential interference contrast (DIC) images and LY fluorescence (green) of control, DFO-, and Dp44mT-treated cells. Not all vacuoles
were sufficiently acidic to massively incorporate LY. Dp44mT-treated cells show a diffuse staining pattern throughout the cytoplasm, which could
correspond to some degree of intracellular membrane permeabilisation. This is an excerpt of the results obtained from several (at least three) experiments.
Scale bars: 100 μm
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These findings strongly suggest that the vacuoles do
not merge with lysosomes or autophagosomes and do
not have acidic content. It was clear that most vacuoles
were initially derived from another source, and one pos-
sibility was that they originated from non-functional late
endosomes.
Iron depletion-induced vacuolisation of cells results from
ER dilation
Immunofluorescence analysis for the lysosomal-associated
membrane protein (LAMP) 1 showed an increase in total
LAMP1 labelling in treated cells (Fig. 4a). Vacuoles were
partially covered by LAMP1. In immunofluorescence mi-
croscopy experiments, DFO- and Dp44mT-induced vacu-
oles in MDA-MB-231 cells were well distinguished using
anti-tubulin and anti-RAB 7 antibodies (Fig. 4b). Proteo-
mics analysis showed that both tubulin and RAB 7 were
up-regulated (Additional files 4, 6). Additionally, the endo-
somal marker, transferrin receptor (TfR), was also up-
regulated by DFO and Dp44mT treatments, as deter-
mined by proteomics analysis (Additional files 4, 6) and
immunofluorescence microscopy experiments (Fig. 4).
These results indicated that vacuoles represented en-
larged late endosomal structures. Large intracellular vac-
uoles are membranous structures derived from
intracellular organelles that are frequently formed in re-
sponse to cell stress [59]. These observations suggested
a possible, previously unidentified link between ER ex-
pansion and the adverse effects of DFO and Dp44mT.
N-myc downstream-regulated gene 1 (NDRG1) is a
stress-responsive protein [60]. Immunofluorescence mi-
croscopy and western blotting data showed an increased
expression of the metastasis suppressor, NDRG1, after
treatment with DFO or Dp44mT. NDRG1 was diffusely
expressed in the cytoplasm and nucleus in untreated cells;
the treatments caused the redistribution of NDRG1 with a
punctate deposition around the vacuoles. NDRG1 partly
co-localised with cytoplasmic and perinuclear tubulin (Fig.
4c), which is in accordance with previous results [61], but
contradicts an earlier interpretation that epithelial–mes-
enchymal transition (EMT) is paralleled by a down-
regulation of NDRG1 expression [62]. Along with NDRG1
overexpression, we observed the loss of cell–cell junctions
and gain of mesenchymal characteristics via overexpression
of the mesenchymal marker, vimentin [63], and decreased
expression of the epithelial marker, beta-catenin (Fig. 4b).
To gain insights into the diversity of vacuolar structures
formed from the expansion of the ER—for instance, if they
are flat and cisternal or highly curved and tubular—we ex-
amined the distribution of reticulon 4 (RTN4), an ER-
shaping protein, that was observed to be up-regulated in our
proteomics analysis (Additional files 4, 6). Figure 4c illus-
trates the sharp demarcation of the tubule-to-vacuole change
at the cell periphery, as displayed by immunostaining of
RTN4. A relatively planar network could be stained in the
thin periphery of the cells, but a dense ER-associated inten-
sity was seen in the perinuclear regions with the increase in
vertical space. This pattern has been described as providing
an increased surface for modulating lipid synthesis or protein
folding [64]. Such a tubular membrane reservoir may also be
needed to facilitate the availability of ER membranes for
modulating interactions with other organelles and intracellu-
lar entities, such as mitochondria, LDs, or endocytic com-
partments [64].
Following the proteomics analysis, we noted a strong
increase in PLINs 2 and 3 (Additional files 4, 6), which
are considered LD scaffold proteins that serve as critical
determinants of LD formation and cellular lipid metab-
olism within mammalian cells [65, 66]. In contrast, sep-
tins regulate the fluid-phase cargo traffic to lysosomes
by promoting macropinosome maturation, and the fu-
sion with endosomes/lysosomes were down-regulated
(Additional files 3, 5).
Disruption of mitochondrial membrane potential (Δψm)
Mitochondria perform important catabolic reactions, such
as the Krebs cycle and oxidative phosphorylation, which
enable efficient ATP generation required for many cell func-
tions. Mitochondria physically interact with the ER, and this
interaction is important for both lipid synthesis and calcium
handling [67]. During nutrient starvation, mitochondria
elongate in order to preserve their metabolic function. To
determine possible changes in mitochondrial distribution as-
sociated with ER expansion, we performed immunostaining
experiments with Rhodamine 123. The Rhodamine 123
staining pattern clearly indicated a change in the mitochon-
drial network morphology after treatment with both
chelators (Fig. 5a), possibly predicting the blockage of
mitochondrial fission. In untreated cells, mitochondria were
distributed throughout the cytosol, with a tendency to ag-
gregate around the nucleus, forming a network. Following
DFO or Dp44mT treatment, we observed fragmented mito-
chondria around ER vacuolar structures. Anti-VDAC1 stain-
ing confirmed this mitochondrial pathway (Fig. 5c). DFO
and Dp44mT caused significant network fragmentation that
typically occurs in response to severe stress, impaired oxida-
tive phosphorylation, and cellular dysfunction [68].
The change in Rhodamine 123 fluorescence intensity
reflects the change in relative levels of ΔΨm or reactive
oxygen species (ROS); consistent changes were observed
in both treatments but with varying degrees. Both treat-
ments produced a bi-parametric population represented
by the intensity of the signals corresponding to the x-
axis evaluated as a function of time (Fig. 5d). Mean
fluorescent intensity of the treated cells decreased with
respect to that of untreated cells.
The expression of the mitochondrial marker SRA stem-
loop interacting RNA-binding protein (SLIRP) decreased at
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72 h (Fig. 5b). SLIRP is required for the correct binding of
mitochondrial mRNAs with the mitochondrial ribosome to
enable efficient translation [69]; its decreased expression
possibly indicates a down-regulation of mitochondrial gene
expression.
Iron chelation induces accumulation of fluid-filled
vacuoles and LDs
The same modifications in phenotype, cell behaviour, and
some representative molecular patterns observed in MDA-
MB-231 were also found in the DFO- or Dp44mT-treated
MDA-MB-157 breast cancer cell line (Fig. 6). This
consistency in the results indicated the existence of a possible
general correlation between iron depletion and the described
effects. To further understand the observed modifications,
we performed further determinations. As described earlier,
after treatment with DFO or Dp44mT, large, swollen
vacuoles appeared suddenly in MDA-MD-231 cells during
the period from 48 to 72 h, and the treated cells showed a
massive accumulation of LDs that stained positively for Oil
Fig. 4 Cell phenotype represents marked dilatation of the rough endoplasmic reticulum (ER). a Cells were treated with DFO or Dp44mT for 48 h,
processed for immunofluorescence, and then observed under a fluorescence microscope. The vacuoles were identified to be positive for late
endosome/macropinosome markers RAB7 and LAMP1. Stars indicate the localisation of RAB7 and LAMP1 surface proteins in the membranes of
vacuoles. TfR was used as a marker for endocytosis. b Western blotting analysis of the expression of the epithelial to mesenchymal transition
markers NDRG1, beta-catenin, and vimentin. The protein lysates were obtained from cells treated with DFO or Dp44mT for the times indicated.
c Localisation of NDRG1 and RTN4 in vacuolated MDA-MB-231 cells. Cells were treated with DFO or Dp44mT for 48 h, processed for
immunofluorescence, and then observed under a confocal microscope. Cells were immunostained with NDRG1 and RTN4 (red) and anti-tubulin
(green) antibodies and then analysed by fluorescence microscopy. Blue, DAPI. Scale bars: 100 μm
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Red O in living as well as dying cells (Fig. 7). The LDs could
be seen interspersed between the clear vacuoles. The treated
cells exhibited considerably increased numbers of LDs, which
is in agreement with the increased expression of PLIN2/
PLIN3 (Additional files 4, 6).
Non-linear light microscopy techniques, such as co-
herent anti-stokes Raman scattering (CARS) microscopy,
was used to determine the vacuolar content and to visu-
alise LDs within a single living cell [39]. The results
showed that cells incorporate large amounts of extracel-
lular material that accumulate into large and transparent
vacuoles. Therefore, the expansion of the ER lumen to
form vacuoles is possibly due to the scavenging of extra-
cellular macromolecules that are needed to sustain cell
survival in a nutrient-depleted environment. The swollen
ER network accumulates lipids to form ER-derived LDs
generated by budding mechanisms.
Finally, when cell swelling occurred 72 h after treat-
ment with the chelators, vacuoles largely disappeared,
and droplets were extruded by the cells. Many of these
droplets converged to form branched aggregated of LDs
(Fig. 7).
LDs are the intracellular sites for neutral lipid storage
with total FA composition that can vary notably. The GC-
MS analysis of LDs derived from both DFO- and
Dp44mT-treated cells showed that the major FAs present
were oleic acid (29.3 and 38.4%, respectively), stearic acid
(27 and 31.5%, respectively), arachidonic acid (ARA, 9.9
and 5.1%, respectively), and palmitic acid (5.9 and 6.26%,
respectively) (Fig. 8). Notably, ARA can be metabolised
into important lipid mediators and signalling molecules.
Myristic acid is a saturated FA produced by FASN and
was observed to be down-regulated by the treatments,
representing only 0.56 and 0.88%, respectively. Oleic acid,
the most abundant FA among the analysed LDs, is a
monounsaturated FA synthesised by the introduction of a
cis double bond at the Δ-9 position of stearic acid (C18)
[70]. This oxidative conversion of stearic acid to oleic acid
is catalysed by the NADH-dependent stearoyl-CoA desa-
turase (SCD), which was not observed to be differentially
expressed in our proteomics analysis (Additional files 3, 4,
5, 6), and that possibly explains the reduced SCD activity
in hypoxia. The lipogenic acetyl-CoA carboxylase
(ACACA) was also down-regulated (Additional files 3, 5).
Fig. 5 Mitochondrial alterations in MDA-MB-231 cells induced by DFO or Dp44mT treatment. a Using confocal microscopy, alterations in mitochondrial
morphology were evaluated using Rhodamine 123 (pink). Differential interference contrast (DIC) images and Rhodamine 123 fluorescence of control
(left), DFO- (centre), and Dp44mT-treated cells (right). Only representative merged images are shown. The treatment with 100 μM DFO or 5 μM
Dp44mT causes ER expansion with vacuolation, which is accompanied by breakage of the mitochondrial network. b Western blot analysis of SLIRP
and BCL-2 expression in total lysates from untreated (NT or DMSO) and treated (DFO or Dp44mT) MDA-MB-231 cells. Tubulin was used as a loading
control. c Cells were observed under an Olympus Fluo View 1000 fluorescence microscope. MDA-MB-231 cells, untreated or treated with DFO, were
labelled with an anti-VDAC antibody (red) followed by appropriate secondary antibodies, anti-tubulin (green), and DAPI (blue). The cells were observed
under an Olympus Fluo View 1000 confocal microscope. Only representative merged images are shown. Scale bars: 100 μm. d Fluorescence-activated
cell sorting (FACS) cytometry assessing mitochondrial depolarisation induced by DFO and Dp44mT
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Previous studies have demonstrated that reduced SCD
activity in hypoxic cells was associated with the scaven-
ging of exogenous monounsaturated FAs to maintain a
viable desaturation index [71]. Otherwise, a sustained ER
stress was observed. In contrast, we observed that the
majority of FAs in LDs were unsaturated; the desatur-
ation index was very high (34% saturated vs 66% desatu-
rated for DFO-treated cells and 39% saturated vs 61%
desaturated for Dp44mT-treated cells), and oleic acid
(29.3 and 38.4%, respectively) was more abundant than
stearic acid (27 and 31.5%, respectively).
The role of LDs was not investigated in the present
study; our results reveal a link between iron depletion,
reduced mitochondrial activity, and LD accumulation
and show that the mono-saturated oleic acid is the most
abundant FA present in the LDs.
Discussion
Iron is an essential nutrient required for many biosynthetic
and metabolic processes, such as haem and sulphur–iron
cluster biosynthesis, oxygen transport, mitochondrial res-
piration, lipid desaturation, and DNA replication [72].
Compared with normal cells, cancer cells require a large
amount of iron for several essential processes. Iron bio-
availability can be affected by the lack of functional vascula-
ture in tumours, resulting in a hypoxic/anaemic tumour
microenvironment. Iron affects the HIF pathway, and iron
deficiency can produce responses similar to hypoxia, as ob-
served from the effects of iron chelation in cell culture and
in humans [73]. However, the effects of iron deficiency on
hypoxia behaviour and signalling mechanisms have not
been completely understood.
Our study provides novel insights on how iron
deprivation modulates the cell structure and the proteomic
and metabolic pathways in breast cancer cells. Prolonged
iron deficiency in cultured tumour cells induces significant
changes in cellular phenotypes and mesenchymal markers
and an adaptive cellular response similar to that induced by
hypoxic stress, prior to killing the tumour cells [74]. HIF-1
was up-regulated in MDA-MB-231 cells (Additional files 4,
6) after treatment with iron chelators, sustaining EMT and
hypoxia programs; mesenchymal marker genes, NDRG1
and vimentin, increased in parallel with the decrease in E-
cadherin expression and the increase in CD44 and CD166
expression, which are well-known cancer stem cell markers
[75] (Additional files 4, 6). Remodelling of iron-starved cells
showed a marked reduction in translation and the increase
of redox pathways, along with perinuclear mitochondrial
Fig. 6 Modifications of morphology and protein expression observed in the cell line MDA-MB-157 during iron depletion. a MDA-MB-157 cells
were treated with 100 μM of the iron chelator DFO for 72 h and photographed under an optical microscope. Scale bars: 100 μm. b MDA-MB-157
cells, untreated or treated with 100 μM DFO for 48 h, were labelled with anti-Rab 7 or anti-TfR antibody (red) followed by appropriate secondary
antibodies, anti-tubulin (green), and DAPI (blue) and observed under an Olympus Fluo View 1000 fluorescence microscope. Only representative
merged images are shown. Scale bars: 100 μm. c Western blot analyses of DFO- or Dp44mT-treated cells showing increased levels of
phosphorylated JNK, beta-catenin, vimentin, and NDGR1. Tubulin was used as a loading control
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clustering disruption, depolarisation, and a hypoxia-like re-
programming of metabolism. The reprogramming suggests
an adaptation of the cancer cells to iron deprivation, which
is accompanied by the augmentation of mesenchymal
characteristics.
The expanded ER formed large vacuoles and a com-
plex network of membranes around the nucleus. Coales-
cent spherical units of translucent material around the
nucleus were stained with lipid dyes such as Oil Red O
and observed using Raman spectroscopy. These struc-
tural modifications occurred in parallel with the in-
creased expression of ER markers (NDRG1 and RTN4)
and LD-associated proteins (PLIN2/PLIN3). Using Ra-
man spectroscopy, we could also determine that the vac-
uoles contained sacs of fluid-filled extracellular medium.
These modifications increased with time of treatment
with DFO or Dp44mT and were tolerated by the cells
before they underwent cytoplasmic collapse, succumbing
to a non-apoptotic and non-autophagic type of death.
Thus, under iron deprivation, breast cancer cells exhib-
ited a large amount of fluid-filled vacuoles and lipid accu-
mulation. A type of extensive vacuolation followed by cell
death, known as methuosis, or death by macropinocytosis
has been previously described as an efficient method for
inducing cell death in different types of cancers [76, 77].
Proteomics analyses of pre-death cells clearly indicated a
striking metabolic plasticity, based on the scavenging of
nutrients destined for short-term cell survival.
By recycling nutrients from intracellular macromole-
cules, autophagy represents an important cellular strat-
egy to sustain viability during periods of limited nutrient
availability [78]. We observed a blocking of autophagy
and possible loss of cell viability, which may be derived
from the cytoplasmic hyper-vacuolisation associated
Fig. 7 Oil Red O staining and label-free CARS imaging of MDA-MB-231 cells after DFO treatment. a Oil Red O staining of MDA-MB-231 cells treated
with DFO for 48 h. Images on the left show cells under a microscope at magnifications of 200× and 400×. Cells were stained with Oil Red O and
counterstained with haematoxylin to show nuclei (N). The cells adopted a round morphology and accumulated large cytoplasmic vacuoles (V) in
which accumulation of lipids (LD) was interspersed. Images on the right show examples of how cell morphology evolves after 72 h of treatment. Cells
shrink before dying with a consistent release of aggregates of floating lipid droplets. b CARS composite images of MDA-MB-231 cells treated with
100 μM DFO for 72 h. Panels show the images of lipids in green (2850 cm− 1) and of the vacuoles and medium (3050 cm− 1); CARS spectra are
also reported
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with the loss of metabolic capacity (as indicated by the
decrease in mitochondrial membrane potential) and
plasma membrane integrity, until osmotic pressure per-
mitted. Cells formed non-acidic and non-autophagic
vacuoles, with massive cytoplasmic vacuolations devel-
oping from the dilation of the ER lumen. The formation
of intracellular vacuoles and subsequent cell death indi-
cated that the events occurring in the ER initiate this de-
structive pathway. This massive dilation of the ER finally
culminates in a paraptosis-like cell death [3], releasing
LDs into the extracellular environment. Consequently,
in vivo anaemic/hypoxic regions in tumours with poor
iron availability may be considered to be at risk for dis-
semination of possible bioactive vesicles.
The association between LD metabolism and cancer cell
survival and metabolism is unknown. LD accumulation
probably results from the increased lipid scavenging activity
in MDA-MB-231 cells, rather than augmented lipogenesis
[79]. In accordance with this view, we observed a reduction
in FASN levels, which could limit the initial step in FA bio-
synthesis, and the KEGG indication of an increase in lipid
degradation, suggesting that cancer cells scavenge lipids
from the extracellular environment. Importantly, hypoxic
cells exhibit increased uptake of unsaturated lipids from
their environment, thus bypassing the requirement for FA
desaturation [80]. In fact, FA desaturases, mainly SCD, are
among the most sensitive targets of oxygen and iron starva-
tion [81]. We observed only a decrease in delta-6 desatur-
ase (FADS2) abundance in treated cells accompanied by
the increase in LD accumulation. Based on this result, we
expected a change in lipid composition with an increase in
saturated FAs. Instead, a large amount of monounsaturated
oleic acid was observed in DFO-and Dp44mT-induced LDs
(29.3 and 38.4% of total FAs), which is generally regarded
as cytoprotective [82]. Although an abundance of saturated
stearic acid (27 and 31.5%), possibly due to the reduction of
desaturase functions, was also observed in the LDs, the un-
saturated/saturated FA ratio indicated a greater content of
unsaturated FAs. Some polyunsaturated FAs observed in
the LD analysis have distinct and contrasting effects in
cancer: arachidonic acid mostly exhibits pro-tumourigenic
effects [82]; eicosapentaenoic (EPA; 20:5, ω-3) and
docosahexaenoic acids (DHA; 22:6, ω-3) possess anti-
tumourigenic, anti-inflammatory, and pro-apoptotic effects
in cancer cells [83].
The mitochondrial dysfunction observed in our studies
does not support an active metabolic role for LDs and
further suggests that other compensatory metabolic ad-
aptations to support cell survival under conditions of
iron starvation must be considered.
Fig. 8 FA quantification by GC-MS. a GC-MS analysis of FAs obtained from LDs. FAs were extracted from LDs purified from DFO- and Dp44mT-
treated cells and subjected to GC-MS analysis as described under ‘Materials and Methods’. The major FA subtypes in the LDs were oleic, stearic,
and arachidonic acids. b Peak number, name of the FA, and FA quantification reported as peak area percentage. c Proportions of unsaturated
and saturated FAs
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Conclusions
Iron depletion in breast cancer cells induced mitochondrial
dysfunction and inhibited the activities of several essential
enzymes requiring iron as a cofactor. The morphological,
proteomic, and metabolic aspects of our study support the
view that cells develop a short-term stress tolerance under
iron depletion, activating a hypoxia-like program with the
uptake of nutrients from the extracellular fluid-phase by
macropinocytosis. However, the blockage of autophagy and
the dysfunctional mitochondrial respiration do not permit a
sufficient level of catabolism to sustain long-term cell sur-
vival. Drastic cell structure changes guided by ER expansion
create two main storage compartments: extracellular fluid-
filled vacuoles and LDs that accumulate lipids because of
the loss of FA oxidation. LDs released after cell death have
potential benefits for study as metabolic entities to
understand the mechanistic and clinical aspects of tumour
biology in future studies.
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